Article Versions Notes

Begagić E, Bečulić H, Đuzić N, Džidić-Krivić A, Pugonja R, Muharemović A, Jaganjac B, Salković N, Sefo H, Pojskić M. CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. Biomedicines. 2024; 12(1):238. https://doi.org/10.3390/biomedicines12010238

Begagić, Emir, Hakija Bečulić, Nermin Đuzić, Amina Džidić-Krivić, Ragib Pugonja, Asja Muharemović, Belma Jaganjac, Naida Salković, Haso Sefo, and Mirza Pojskić. 2024. "CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review" Biomedicines 12, no. 1: 238. https://doi.org/10.3390/biomedicines12010238

Begagić, E., Bečulić, H., Đuzić, N., Džidić-Krivić, A., Pugonja, R., Muharemović, A., Jaganjac, B., Salković, N., Sefo, H., & Pojskić, M. (2024). CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. Biomedicines, 12(1), 238. https://doi.org/10.3390/biomedicines12010238